Savannah Wetzler
Physician Assistant · Groesbeck, TXNPI 1851713275
Payments from drug & device makers
Across 149 payments — averaging $14.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$745
- AbbVie$459
- Amgen$140
- Otsuka America Pharmaceutical, Inc.$121
- Bayer$91
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$88
- plus $482 from 11 others
What the payments were for
- Food & beverage$2,127100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 65 | $745 |
| AbbVie | 26 | $459 |
| Amgen | 7 | $140 |
| Otsuka America Pharmaceutical, Inc. | 6 | $121 |
| Bayer | 6 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $88 |
| Lilly USA, LLC | 4 | $86 |
| Merck | 5 | $82 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $67 |
| GSK | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 8 | $51 |
| AstraZeneca | 3 | $51 |
| Boehringer Ingelheim | 2 | $33 |
| Abbott | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $4 |
How this compares
$2,127 in reported general payments places this provider in the 75th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 121 | $112,497 |
| MounjaroTirzepatide | 84 | $88,639 |
| RybelsusSemaglutide | 44 | $65,209 |
| JardianceEmpagliflozin | 41 | $28,612 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $11,563 |
| Breo ElliptaFluticasone/Vilanterol | 27 | $11,064 |
| EliquisApixaban | 15 | $9,482 |
| Tresiba Flextouch U-100Insulin Degludec | 27 | $6,970 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $3,245 |
| Gabapentin | 120 | $2,760 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 49 | $1,715 |
| Fluticasone Propionate | 72 | $1,477 |
| Rosuvastatin Calcium | 126 | $1,435 |
| Atorvastatin Calcium | 138 | $1,276 |
| Pantoprazole Sodium | 85 | $1,079 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $745 | $177,707165 claims |
| Lilly USA, LLCMounjaro | $86 | $88,63984 claims |
| Boehringer IngelheimJardiance | $33 | $28,61241 claims |
| GSKBreo Ellipta | $58 | $11,06427 claims |
| AbbVieSynthroid | $459 | $66614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Groesbeck
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.